In CRC, the reactivation or remodeling of mitochondrial metabolic pathways, particularly oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO), is closely associated with key oncogenic processes such as the evasion of apoptosis, the maintenance of cancer stem cell properties, and the regulation of redox homeostasis [5,6,7,8]
However, the exact mechanisms underlying these effects remain unclear, particularly whether the cognitive improvements are a direct result of GLP-1 action or are mediated indirectly via enhanced glucose regulation
They are legal when prescribed by a licensed physician and prepared by a licensed pharmacy, but they are fundamentally different products from a regulatory standpoint
Create Serious Penalties for Violations Fine pharmacies up to $1,000 per dose for drugs deemed improperly compounded Allow immediate license revocation Require warning labels stating the drug is not FDA-approved and may have known and unknown risks Whats worse is that some of these bills dont just target GLP-1s, they target all compounding
